Carisoprodol in the treatment of myofascial pain-dysfunction syndrome.
The effects of carisoprodol and a placebo were compared in a sample of 60 patients with the clinical diagnosis of myofascial pain-dysfunction syndrome using double-blind design.  Carisoprodol failed to show a significantly greater effect than the placebo.  The side effects were about the same with both agents.
D000293:Adolescent; D000328:Adult; D000368:Aged; D002328:Carisoprodol / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D005152:Facial Muscles; D005260:Female; D006801:Humans; D008297:Male; D008410:Masticatory Muscles; D008875:Middle Aged; D009135:Muscular Diseases / Q000188:drug therapy*; D010146:Pain / Q000188:drug therapy*; D010919:Placebos / Q000627:therapeutic use; D013577:Syndrome
D010919:Placebos; D002328:Carisoprodol